Fermenta Biotech on Friday said its board has approved transferring its environmental solutions business to a wholly owned subsidiary on a slump sale basis, effective October 1, 2025.
from Healthcare/Biotech-Industry-Economic Times https://ift.tt/gJwf19o
via IFTTT
-
Acquista ********, Ossicodone, Ketamina, Ozempic (WhatsApp: +31616337954) I nostri prodotti hanno una purezza del 98-99%. E-mail di cont...
-
So I’m currently on a lean bulk on 2900 a day. And I wake up 6 am I have oats and protein powder or fruit then go gym around 9 am Then at ...
-
Kotak Alternate Asset Managers has announced a Rs 1,445 crore investment in the acquisition of Viatris' active pharmaceutical ingredient...
Search This Blog
Powered by Blogger.
Blog Archive
-
▼
2025
(694)
-
▼
September
(77)
- Bayer seeks approval for key heart drug in India
- Global report says 40% of clinicians in India coul...
- To what extent will Trump's tariffs impact Indian ...
- Managing diabetes early: A smart choice to consider
- Lupin subsidiary inks pact to acquire Netherlands-...
- 'Indian generics safe, tariffs unwise': Indian pha...
- Veterinary vaccine firms form association for coll...
- Glenmark, Granules, Zydus recall products in US ov...
- Highs & Lows: Could the microdosing of psychedelic...
- Just like bad medicine...Trump tariff pricks again...
- Weight-loss drug Ozempic to debut in India soon
- Diabesity: It’s more than you think
- Trump delivers another bitter tariff pill. Who’s s...
- Trump's 100% tariff on pharma will not impact gene...
- Meril’s Mizzo Endo 4000 sets a new benchmark in ro...
- Alembic Pharma gets USFDA nod for generic drug to ...
- HIV-prevention drug to cost $40 a year from 2027
- HCA Healthcare to invest $75 mln to set up Global ...
- Tata 1mg likely to get $200 mn booster shot; Novo,...
- India’s liver-heart-diabetes triangle: Why acting ...
- Vidal Health and Serum Institute collaborate on HP...
- India’s cheap birth control pills in US could vani...
- India’s unique diabetes profile: The Indian diabet...
- Drug companies flag concerns over timeline for car...
- PE fund KKR closes third buy in Kerala, at Meitra ...
- Rehabilitation: India's 'missing link' in healthcare
- India push into global natural healthcare market, ...
- "Transformative shift in India's healthcare": Phar...
- Healthcare set to be more affordable as new GST ra...
- Fermenta board approves sale of environmental solu...
- Fire at subsidiary unit temporarily hits productio...
- PMO acts on pharma MSMEs 'crisis call'
- Indian pharma sector to log 7-9% growth in FY26 de...
- Natco Pharma's Kothur unit classified as 'voluntar...
- India ranks among top contributors in reporting ad...
- AstraZeneca's asthma drug fails 'smoker's lung' study
- 'Nimesulide' may come with warning label
- Novo Nordisk to test weight-loss drugs in broader ...
- Scheme to promote innovation in pharma, medtech se...
- In major move, patent of Novartis' blockbuster car...
- Novo Holdings in talks to buy into Surya Hospitals
- India’s heart-risk score in diabetes: Why every In...
- Roche Pharma partners with 10 govt hospitals to bo...
- Reckitt has joined hands with PATH-CHRI to Launch ...
- Why Indians skip the flu vaccine despite risks
- Creador to buy 7% stake in pharma company La Renon
- Pharma exporters seek rollback of rule banning exp...
- Cupid announces strategic investment in fragrance ...
- Biocon inaugurates first manufacturing facility in US
- Dr Reddy's inks pact with Johnson & Johnson to acq...
- Delhi HC stops drug body from taking action agains...
- Indian hospitals to raise IT innovation spend by 2...
- WHO adds popular weight-loss drugs to essential me...
- Medicines may soon come with braille labels, audio...
- Indian pharma sector needs price hikes, site and I...
- The missed window: Why half of India’s people with...
- Health experts alarmed by GST cut on beedis, deman...
- AstraZeneca to invest Rs 176 cr to expand GITC in ...
- USFDA issues Form 483 with 8 observations to Aurob...
- Glenmark initiates multi-nation Phase 3 clinical t...
- Type 2 diabetes triggering heart attacks in the 30...
- Pharma companies cheer lower drug prices, API tax ...
- GST cut on drugs, medical devices to provide relie...
- Crucial drugs to be more affordable after GST cut
- Centre set to amend rules to simplify drug testing...
- Alkem's Enzene powers into US with $70 m investment
- Singapore-based firm proposes to acquire 25% in We...
- Lupin gets USFDA nod for generic risperidone exten...
- Caplin Point arm gets USFDA nod for milrinone lact...
- Medical device manufacturers allowed to give free ...
- India eyes Russia, Brazil, Netherlands for pharma ...
- Glenmark launches generic cancer treatment drug in US
- Zydus launches VaxiFluTM trivalent influenza vacci...
- Fortis Healthcare arm inks 15-year lease with RR L...
- The #WeightofDiabetes iceberg: Why the real burden...
- Govt launches advanced biomanufacturing hubs to bo...
- Novo Nordisk ties up with Apollo Clinics for obesi...
-
▼
September
(77)
Recent Posts
Unordered List
Theme Support
-
Text Widget
Design by FlexiThemes | Blogger Theme by Lasantha - PremiumBloggerTemplates.com | Best Gadgets | Distributed By Gooyaabi Templates
0 comments:
Post a Comment